// App-Quantinova.ai

FRI0061 : REMISSION AFTER ONE YEAR FOLLOW UP OF THE IMPROVED-STUDY, A RANDOMIZED CLINICAL TRIAL AIMING AT REMISSION IN PATIENTS WITH EARLY RHEUMATOID AND UNDIFFERENTIATED ARTHRITIS

Researchers

Presenter

  • L. Heimans

Principal Investigators

  • K.V.C. Wevers-de Boer

  • K. Visser

  • T.W. Huizinga

  • C.F. Allaart

  • H.K. Ronday

  • M. Oosterhout

  • J.B. Harbers

  • A.J. Peeters

  • M.L. Westedt

  • P.D. de Buck

  • P.B. de Sonnaville

  • B.A. Grillet

Medical Centers

  • Reumatology, Zorgsaam Terneuzen, Terneuzen, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • sulphasalazine

  • Methotrexate

  • Adalimumab

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved